Published in J Clin Endocrinol Metab on May 20, 2008
Acromegaly pathogenesis and treatment. J Clin Invest (2009) 2.19
A consensus on the diagnosis and treatment of acromegaly complications. Pituitary (2013) 1.26
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly. Pituitary (2010) 1.22
From somatostatin to octreotide LAR: evolution of a somatostatin analogue. Curr Med Res Opin (2009) 1.10
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary (2016) 0.83
Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis. PLoS One (2013) 0.82
Medical therapy of acromegaly. Int J Endocrinol (2012) 0.82
Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question. J Clin Endocrinol Metab (2008) 0.80
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome. Pituitary (2010) 0.79
Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Acta Neurochir (Wien) (2011) 0.78
Medical management of functioning pituitary adenoma: an update. Neurol Med Chir (Tokyo) (2014) 0.77
The role of primary pharmacological therapy in acromegaly. Pituitary (2014) 0.77
Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients. BMC Endocr Disord (2014) 0.76
Management of acromegaly. F1000 Med Rep (2010) 0.76
Clinical importance of achieving biochemical control with medical therapy in adult patients with acromegaly. Patient Prefer Adherence (2016) 0.75
Pituitary function: Acromegaly: where are we now? Nat Rev Endocrinol (2009) 0.75
Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary (2013) 0.75
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet (2003) 2.86
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab (2009) 2.01
Conservative management or gamma knife radiosurgery for vestibular schwannoma: tumor growth, symptoms, and quality of life. Neurosurgery (2013) 2.01
Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab (2007) 1.99
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96
Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol (2011) 1.88
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol (2004) 1.88
Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry (2012) 1.87
Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res (2007) 1.82
Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery (2009) 1.77
Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens (2005) 1.75
Growth of untreated vestibular schwannoma: a prospective study. J Neurosurg (2012) 1.66
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Nutr Metab Cardiovasc Dis (2007) 1.62
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
The vertebral body fracture in osteoporosis: restoration of height using percutaneous vertebroplasty. AJNR Am J Neuroradiol (2005) 1.53
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol (2005) 1.49
[A 90-year-old woman with acute hemiparesis]. Tidsskr Nor Laegeforen (2006) 1.48
Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res (2007) 1.48
Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly. J Clin Endocrinol Metab (2012) 1.44
Treatment of type 1 diabetes in the specialist health service--data from the Norwegian Diabetes Register for Adults. Tidsskr Nor Laegeforen (2013) 1.44
Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) (2011) 1.43
Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels. Thromb Haemost (2009) 1.42
Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred. J Hum Genet (2006) 1.38
Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol (2002) 1.35
Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. J Clin Endocrinol Metab (2004) 1.34
Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol (2004) 1.31
Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol (2005) 1.26
Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology (2008) 1.24
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One (2012) 1.23
Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab (2006) 1.19
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol (2009) 1.19
Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol (2009) 1.19
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol (2010) 1.18
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery (2005) 1.16
Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res (2002) 1.14
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol (2013) 1.13
The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol (2013) 1.13
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13
Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study. Scand J Public Health (2010) 1.10
Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab (2014) 1.09
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res (2011) 1.06
Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand (2008) 1.06
Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol (2010) 1.05
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathol (2014) 1.04
Location, sidedness, and sex distribution of intracranial arachnoid cysts in a population-based sample. J Neurosurg (2010) 1.04
Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway. BMC Health Serv Res (2010) 1.03
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol (2011) 1.03
Fetal growth versus birthweight: the role of placenta versus other determinants. PLoS One (2012) 1.03
High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (2011) 1.02
Newborn body fat: associations with maternal metabolic state and placental size. PLoS One (2013) 1.00
Adiposity-related inflammation: effects of pregnancy. Obesity (Silver Spring) (2013) 0.99
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol (2008) 0.98
Increased NKCC1 expression in arachnoid cysts supports secretory basis for cyst formation. Exp Neurol (2010) 0.97
Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study. Eur J Epidemiol (2010) 0.97
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg (2015) 0.95
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol (2006) 0.95
Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering. J Magn Reson Imaging (2009) 0.94
Physical activity and calcium consumption are important determinants of lower limb bone mass in older women. J Bone Miner Res (2004) 0.94
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity. Orphanet J Rare Dis (2014) 0.94
Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res (2013) 0.94
Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas. Neurosurgery (2010) 0.94
Predictive modeling in glioma grading from MR perfusion images using support vector machines. Magn Reson Med (2008) 0.94
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) (2012) 0.93
Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Matern Fetal Neonatal Med (2010) 0.92
Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol (2007) 0.92
Shape information from glucose curves: functional data analysis compared with traditional summary measures. BMC Med Res Methodol (2013) 0.91
Surgical Decompression of Arachnoid Cysts Leads to Improved Quality of Life: A Prospective Study. Neurosurgery (2016) 0.91
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency. Eur J Endocrinol (2006) 0.91
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol (2013) 0.90
Mechanisms of tumor cell invasion and angiogenesis in the central nervous system. Front Biosci (2003) 0.90
Microarray-based gene expression profiling and DNA copy number variation analysis of temporal fossa arachnoid cysts. Cerebrospinal Fluid Res (2010) 0.90
Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life. Neurosurgery (2006) 0.89
Imaging of experimental rat gliomas using a clinical MR scanner. J Neurooncol (2003) 0.89
Acute visual loss after spinal surgery. Acta Ophthalmol (2009) 0.88
Isolated sulfite oxidase deficiency: MR imaging features. AJNR Am J Neuroradiol (2002) 0.88
Understanding coupling between bone resorption and formation: are reversal cells the missing link? Am J Pathol (2013) 0.88
Seasonal variation in maternal and umbilical cord 25(OH) vitamin D and their associations with neonatal adiposity. Eur J Endocrinol (2014) 0.88
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab (2010) 0.88
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res (2010) 0.88
Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. Eur J Endocrinol (2002) 0.88
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma. Clin Endocrinol (Oxf) (2007) 0.87
[Quality of diabetes care in Norwegian general practice]. Tidsskr Nor Laegeforen (2008) 0.87
Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: a study of healthy individuals and patients with Cushing's syndrome. J Bone Miner Res (2012) 0.87
Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men. Int J Androl (2008) 0.86
Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol (2009) 0.86
Assessing body composition in healthy newborn infants: reliability of dual-energy x-ray absorptiometry. J Clin Densitom (2010) 0.86
Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med (2014) 0.86
Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes (2012) 0.86
Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res (2005) 0.86